Bloodstream Infection Testing Market Analysis

Product (Instruments, Reagents & Consumables)

Reagents & consumables segment is expected to dominate bloodstream infection testing market share of over 69% by 2036. The segment growth can be attributed to the effortless availability and high purchase of screening products for blood donors and recipients.

Moreover, the broad range of blood grouping, typing, and donor screening reagents, kits, and assays which are offered by global and local manufacturers drive the growth of consumables segment. According to the United Nations Children’s Fund (UNICEF), the number of AD syringes UNICEF procured grew from 11 million in 1997 to around 600-800 million per year. It is also the world’s largest buyer of AD syringes, procuring 40% of the global market.

Application (Bacterial, Fungal, Mycobacterial)

In bloodstream infection testing market, bacterial segment is set to account for revenue share of around 65% by 2036. The segment growth can be attributed to the increasing cases of bacterial infections such as pneumonia or meningitis. Bacteria can enter the bloodstream of the human body as a severe side effect of other infections during surgery or due to catheters.

Moreover, bacterial infections in the blood can have several serious health effects. According to WHO, around half (20 million) of all predicted sepsis cases recorded across the world occurred in children under 5 years of age, and for every 1000 hospitalized patients, around 15 patients will develop sepsis as a complication of receiving health care. Furthermore, increasing cases of sepsis are foreseen to be the major driving factor for the market.

End-User (Hospitals, Independent Diagnostics Centers, Others)

By 2036, hospital segment is estimated to capture bloodstream infection testing market share of over 55%. The reason behind segment growth is the increasing number of hospitals as these are the primary place for diagnosis of bloodstream infection. The patient with symptoms of bloodstream infection first gets in touch with the hospital, as these places are equipped with advanced technologies including diagnostic laboratories, equipment, and experienced healthcare professionals.

They frequently perform a high volume of bloodstream infection tests on both inpatients and outpatients, making them a key player in the market.  As per the latest report, more than 317,705 hospital admissions took place due to sepsis during the period from 2008 to 2021. Around 222,832 of the patients were admitted to hospital for the first time due to sepsis. Moreover, the improving healthcare facilities in developing countries along with the growing number of independent laboratories with hospital beds and supporting equipment is the main factor driving the bloodstream infection testing market.

Our in-depth analysis of the global market includes the following segments: